Impact of genomic testing on urologists' treatment preference in favorable risk prostate cancer: A randomized trial.
Carbunaru S, Sun Z, McCall C, Ofori B, Marshall N, Wang H, Abern M, Liu L, Hollowell CMP, Sharifi R, Vidal P, Kajdacsy-Balla A, Sekosan M, Ferrer K, Wu S, Gallegos M, Gann PH, Moreira D, Sharp LK, Ferrans CE, Murphy AB.
Carbunaru S, et al. Among authors: sharp lk.
Cancer Med. 2023 Oct;12(19):19690-19700. doi: 10.1002/cam4.6615. Epub 2023 Oct 3.
Cancer Med. 2023.
PMID: 37787097
Free PMC article.
Clinical Trial.